Voss Capital, LLC Lantern Pharma Inc. Transaction History

Voss Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.34 - $21.92 $371,492 - $567,859	-25,906 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.1 - $20.69 $138,331 - $189,541	-9,161 Reduced 26.12%	25,906 $499,000
Q3 2020 Nov 12, 2020	BUY	$10.7 - $21.25 $375,216 - $745,173	35,067 New	35,067 $661,000

1.29M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $38.3M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Voss Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Voss Capital, LLC with notifications on news.